SCOPUS 정보 검색 플랫폼

Clinical and Applied Thrombosis/Hemostasis

Volumn 6, Issue 3, 2000, Pages 157-161

Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemia

(5) Laguna, María Susana a Kornblihtt, Laura I a Marta, Rosana F a Michiels, Jan Jacques b Molinas, Felisa C c

a UNIVERSIDAD DE BUENOS AIRES (Argentina)

b Goodheart Institute (Netherlands)

c ACADEMIC MEDICAL CENTER (Netherlands)

Author keywords

Anagrelide; Bleeding; Essential thrombocythemia; Spontaneous platelet aggregation; Thrombosis

Indexed keywords

ANAGRELIDE;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REMISSION; SYMPTOMATOLOGY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; VEIN THROMBOSIS;

ADULT; AGED; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; QUINAZOLINES; THROMBOCYTOSIS;

EID: 0033840802 PISSN: 10760296 EISSN: None Source Type: Journal
DOI: 10.1177/107602960000600307 Document Type: Article

Times cited : (34)

References (34)

1
- 0021914091
- Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis
- (1985) Ann Int Med , vol.102 , pp. 466
- Michiels, J.J.¹ Abels, J.² Steketee, J.³

2
- 0030748534
- Erythromelalgia and thrombocythemia: A disease of platelet prostaglandin metabolism
- (1997) Sem Thromb Hemostas , vol.23 , pp. 335
- Michiels, J.J.¹

3
- 0032909014
- Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia
- (1999) Clin Appl Thrombosis/Hemostasis , vol.5 , pp. 30
- Michiels, J.J.¹

4
- 0025159142
- Erythromelalgia and Thrombocythemia: A causal relation
- (1990) J Amer Acad Dermatol , vol.22 , pp. 107
- Michiels, J.J.¹ Van Joost, T.H.²

5
- 0027156888
- Transient neurologic and ocular manifestations in primary thrombocythemia
- (1993) Neurology , vol.43 , pp. 1107
- Michiels, J.J.¹ Koudstaal, P.J.² Mulder, A.H.³

6
- 0025807034
- Thrombocythemia and coronary artery disease
- (1991) Am Heart J , vol.122 , pp. 573
- Scheffer, M.G.¹ Michiels, J.J.² Simoons, M.L.³

7
- 0008163362
- Spontaneous aggregation of blood platelets as a cause of idiopathic and recurrent painful toes and fingers
- (1971) Lancet , vol.2 , pp. 1394
- Vreeken, J.¹ Van Aken, W.S.²

8
- 0028831268
- Platelet consumption in thrombocythemia complicated by erythromelalgia: Reversal by aspirin
- (1995) Thromb Haemost , vol.73 , pp. 210
- Van Genderen, P.J.J.¹ Michiels, J.J.² Van Strik, R.³

9
- 0029847674
- Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation
- (1996) Thromb Haemost , vol.76 , pp. 333
- Van Genderen, P.J.J.¹ Lucas, I.S.² Van Strik, R.³

10
- 0029962593
- Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia
- (1996) Leuk Lymph , vol.22 , pp. 47
- Michiels, J.J.¹ Van Genderen, P.J.J.² Lindemans, J.³

11
- 0030887759
- Prevention and treatment of thrombotic complications in essential thrombocythemia: Efficacy and safety of aspirin
- (1997) Br J Haematol , vol.97 , pp. 179
- Van Genderen, P.J.J.¹ Mulder, P.G.H.² Waleboer, M.³

12
- 0023941644
- Anagrelide: A potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity
- (1988) Biochem Pharmacol , vol.37 , pp. 2866
- Gillespie, E.¹

13
- 0021709130
- Inhibition of platelet production induced by an antiplatelet drug, anagrelide, in normal volunteers
- (1984) Thromb Haemost , vol.52 , pp. 325
- Abe Andes, W.¹ Novek, R.J.² Fleming, J.S.³

14
- 9844256082
- The effects of anagrelide on human megakaryocytopoiesis
- (1997) Br J Haematol , vol.99 , pp. 174
- Solberg, L.A.¹ Tefferi, A.² Oles, K.J.³

15
- 0023946455
- Anagrelide: A new drug for treating thrombocytosis
- (1988) N Engl J Med , vol.318 , pp. 1292
- Silverstein, M.N.¹ Petitt, R.M.² Solberg, L.A.³

16
- 0037483282
- Anagrelide, a therapy for thrombocythemic states: Experience in 577 patients
- (1992) Am J Med , vol.92 , pp. 69

17
- 0022743745
- Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group
- (1986) Semin Hematol , vol.23 , pp. 177
- Murphy, S.¹ Hand, H.² Rosenthal, D.³

18
- 0031046485
- Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
- (1997) Semin Hematol , vol.34 , pp. 29
- Murphy, S.¹ Peterson, P.² Hand, H.³

19
- 85018812186
- Practical statistics for medical research. Chapman and Hall. London
- (1991)
- Altman, D.G.¹

20
- 0003065440
- Coexistencia de hiporreactividad y de activacion plaquetaria en la trombocitemia esencial
- (1997) Rev Iberoamer Tromb Hemost , vol.10 , pp. 87
- Laguna, M.S.¹ Marta, R.F.² Kornblihtt, L.I.³

21
- 0017873665
- Platelet hyperaggregability and thrombosis in patients with thrombocythemia
- (1978) Ann Int Med , vol.88 , pp. 7
- Wu, K.K.¹

22
- 0016276375
- Essential thrombocythemia and peripheral gangrene
- (1974) BMJ , vol.3 , pp. 548
- Preston, F.E.¹ Emmanuel, I.G.² Winfield, D.A.³

23
- 0029966248
- Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes
- (1996) Leuk Lymph , vol.22 , pp. 71
- Finazzi, G.¹ Michiels, J.J.²

24
- 0026070916
- Platelet aggregation in platelet rich plasma and whole blood in 120 patients with myeloproliferative disorders
- (1991) Am J Clin Pathol , vol.95 , pp. 82
- Balduini, C.L.¹ Bertolino, G.² Noris, P.³

25
- 0025213422
- Incidence and risk factors of 100 patients with essential thrombocythemia
- (1990) J Clin Oncol , vol.8 , pp. 556
- Cortelazzo, S.¹ Viero, P.² Finazzi, G.³

26
- 0032753792
- Aspirin and platelet lowering agents for the prevention of vascular complications in essential thrombocythemia
- in press
- (1999) Clin Appl Thrombosis/Hemostasis
- Michiels, J.J.¹

27
- 0032975906
- Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia
- (1999) Clin Appl Thrombosis/Hemostasis , vol.5 , pp. 147
- Michiels, J.J.¹

28
- 0030814715
- Aspirin in essential thrombocythemia: Status quo and quo vadis
- (1997) Semin Thromb Hemostas , vol.23 , pp. 371
- Griesshammer, M.¹ Bangerter, M.² Van Vliet, H.H.D.M.³

29
- 0028913012
- Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis
- (1995) N Engl J Med , vol.332 , pp. 1132
- Cortelazzo, S.¹ Finazzi, G.² Ruggeri, M.³

30
- 0032872239
- Leukemogenic events following treatment in essential thrombocythemia
- (1999) Ann Hematol , vol.78 , pp. 389
- Finazzi, G.¹ Barbui, T.²

31
- 0026023062
- Essential thrombocythemia in a child: Management with anagrelide
- (1991) Am J Pediatr Hematol Oncol , vol.13 , pp. 52
- Chintagumpala, M.M.¹ Steuber, C.P.² Mashoney, D.H.³

32
- 85018829905
- Acquired von Willebrand disease type II as the presenting symptom of essential hemorrhagic thrombocythemia in a child: Effectiveness of anagrelide, in press
- Michiels, J.J.¹ Budde, U.² Meier-Hunziger, R.³

33
- 0031830861
- Anagrelide, a novel platelet lowering option in essential thrombocythemia: Treatment experience in 48 patients in Germany
- (1998) Eur J Haematol , vol.61 , pp. 71
- Petrides, P.E.¹ Beykirch, M.K.² Trapp, O.M.³

34
- 0030803837
- Anagrelide as a new platelet-lowering agent in essential thrombocythemia: Mechanism of action, efficacy, toxicity, current indications
- (1997) Sem Thromb Hemostas , vol.23 , pp. 378
- Tefferi, A.¹ Silverstein, M.N.² Petitt, R.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.